Farlow_2000_Eur.Neurol_44_236

Reference

Title : A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease - Farlow_2000_Eur.Neurol_44_236
Author(s) : Farlow M , Anand R , Messina J, Jr. , Hartman R , Veach J
Ref : Eur Neurol , 44 :236 , 2000
Abstract : Farlow_2000_Eur.Neurol_44_236
ESTHER : Farlow_2000_Eur.Neurol_44_236
PubMedSearch : Farlow_2000_Eur.Neurol_44_236
PubMedID: 11096224

Related information

Citations formats

Farlow M, Anand R, Messina J, Jr., Hartman R, Veach J (2000)
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
Eur Neurol 44 :236

Farlow M, Anand R, Messina J, Jr., Hartman R, Veach J (2000)
Eur Neurol 44 :236